Author

Mariann Rutka 1

1 University of Szeged,Szeged,Hungary

ADVANCES IN OPTIMALIZATION OF THERAPEUTIC DRUG MONITORING USING MUCOSAL TNF EXPRESSION AND ANTI-TNF CONCENTRATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGICALS - PRELIMINARY RESULTS FROM A SINGLE CENTER STUDY

Klaudia Farkas, Gréta Elekes, Diána Kata, Imre Földesi, Tamás Ferenci, Tamara Madacsy, Mariann Rutka, Anita Balint, Renáta Bor, Anna Fabian, Ágnes Milassin, Szilvia Lada, Zoltan Gabor Szepes, Ferenc Nagy, József Maléth, Tamás Molnár

CLINICAL ROLE, OPTIMAL TIMING AND FREQUENCY OF MEASUREMENT OF SERUM INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODY TITERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Renáta Bor, Klaudia Farkas, Anita Balint, Ágnes Milassin, Mariann Rutka, Mária Matuz, Ferenc Nagy, Anna Fabian, Zoltan Gabor Szepes, Tamás Molnár

CORRELATION OF HISTOLOGICAL ACTIVITY AND BASAL PLASMACYTOSIS WITH MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS

Klaudia Farkas, Zita Reisz, Anita Sejben, László Tiszlavicz, Mónika Szűcs, Zoltan Gabor Szepes, Ferenc Nagy, Mariann Rutka, Anita Balint, Renáta Bor, Ágnes Milassin, Tamás Molnár

COST-EFFECTIVENESS TRIAL OF SELF-EXPANDABLE METAL STENTS AND PLASTIC BILIARY STENTS IN MALIGNANT BILIARY OBSTRUCTION

Anna Fabian, Renáta Bor, Timea Daróczi, Klaudia Farkas, Anita Balint, Ferenc Nagy, Ágnes Milassin, Mariann Rutka, Mónika Szűcs, Tamás Molnár, Zoltan Gabor Szepes

DOES ANY CONNECTION EXIST BETWEEN BLOOD THIOPURINE LEVEL AND ANTI TNF DRUG LEVEL OR BODY COMPOSITION PARAMETERS - A CROSS-SECTIONAL STUDY IN A HUNGARIAN IBD CENTRE

Kata Szántó, Anna Fabian, András Lajos Szíjártó, Imre Földesi, Diána Kata, Zoltán András Mezei, Anita Balint, Renáta Bor, Klaudia Farkas, Ágnes Milassin, Mariann Rutka, Zoltan Gabor Szepes, Ferenc Nagy, Tamás Bubán, Szilvia Lovas, Karoly Palatka, Tamás Molnár

EFFECT OF INFLUENZA VACCINATION ON THE ACTIVITY OF INFLAMMATORY BOWEL DISEASE

Mariann Rutka, Klaudia Farkas, Ferenc Nagy, Mónika Sz?cs, Anna Fabian, Renáta Bor, Ágnes Milassin, Anita Balint, Zoltan Gabor Szepes, Tamás Molnár

EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Barbara Dorottya Lovasz, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Lilla Laura Lakner, Árpád V. Patai, Ágnes Szabone Salamon;;

EFFICACY OF INFLIXIMAB BIOSIMILAR CT-P13 INDUCTION THERAPY ON MUCOSAL HEALING IN ULCERATIVE COLITIS

Tamás Molnár, Renáta Bor, Mariann Rutka, Petra Anna Golovics, Zsuzsanna Vegh, Barbara Dorottya Lovasz, Tibor Nyári, Krisztina Barbara Gecse, Martin Kolar, Martin Bortlík, Dana Duricova, Nadezda Machkova, Veronica Hruba, Martin Lukas, Katarina Mitrova, Karin Malíčková, Anita Balint, Ferenc Nagy, Renáta Bor, Ágnes Milassin

EFFICACY OF THE NEW INFLIXIMAB BIOSIMILAR CT-P13 INDUCTION THERAPY ON MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS

Tamás Molnár, Klaudia Farkas, Mariann Rutka, Petra Anna Golovics, Peter L Lakatos, Karoly Palatka, Tibor Nyári, Krisztina Barbara Gecse, Anita Balint, Ferenc Nagy, Renáta Bor, Ágnes Milassin, Zoltan Gabor Szepes

EFFICACY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH SEVERE, THERAPEUTIC RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Klaudia Farkas, Pal Miheller, Karoly Palatka, Tamás Szamosi, Peter L Lakatos, Krisztina Barbara Gecse, Petra Anna Golovics, Aron Vincze, Lilla Lakner, Mariann Rutka, Anita Balint, Anna Fabian, Ágnes Milassin, Zoltan Gabor Szepes, Tamás Molnár

Item 1 - 10 / 37
1
2 3 4